Sorrento Therapeutics, BGN partner to develop therapeutic antibodies for ... News-Medical.net Sorrento Therapeutics, Inc. (OTCQB: SRNE; Sorrento) and B.G. Negev Technologies and Applications Ltd., the technology transfer company of Ben-Gurion University of the Negev (BGU), have announced an option and license agreement to develop ... Sorrento, BG Negev partner to develop anti-hepatitis C virus antibodies |
